Recruiting

Characterization of Cardiovascular Risk Profile and Therapeutic Management in Patients With Type 2 Diabetes Mellitus in Italy

CardioMET is an observational, multicenter, real-life registry, intending to collect data on patients with Type 2 Diabetes Mellitus, attending internal medicine and cardiology outpatient clinics. The aim of the registry is to characterize the cardiovascular risk profile and pharmacological management of Type 2 Diabetes Mellitus in Italy, in accordance with current ESC and AHA guidelines for primary and secondary prevention of CV disease.

ClinicalTrials.gov IDNCT07375069

PhaseNot Applicable

Enrollment3000

SponsorFederico II University

Age18 Years

SexALL

I'm interested View official listing

Conditions studied

Type 2 Diabetes

About this study

Interventions

Other: data collection — Data collection on diabetes therapy and follow-up

Primary outcomes

Diabetes treatment adherence according to the most recent European Guidelines (12-24-36-48 months)

Eligibility information

Inclusion Criteria: * Age ≥ 18 years; * Diagnosis of type 2 diabetes mellitus (T2DM); * Stable clinical conditions * Outpatient settings * Ability to understand the study procedures and provide written informed consent. Exclusion Criteria: * Patients with type 1 diabetes mellitus; * Active participation in interventional studies; * Any condition that may put the patient at risk by participating in the study.

Study locations

Federico II University of Naples, Department of Advanced Biomedical Sciences, Naples, Napoli 80131 Italy

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.